Case Study – Page 13

Label reconciliation failure during deviation review – regulatory reporting outcome

Addressing Label Reconciliation Failures in Deviation Reviews: A Case Study In today’s highly regulated pharmaceutical landscape, maintaining rigorous control over labeling and packaging processes is critical to ensuring compliance and…

Packaging deviation repeated during artwork change – regulatory reporting outcome

Investigation of Repeated Packaging Deviations During Artwork Changes In the highly regulated pharmaceutical environment, maintaining the integrity of packaging and labeling processes is critical. An ongoing issue at a mid-sized…

Incorrect artwork version used during inspection – CAPA ineffectiveness analysis

Analysis of CAPA Ineffectiveness Due to Incorrect Artwork Version During Inspection In the highly regulated pharmaceutical industry, any deviation from established protocols can have significant repercussions. A recent incident involving…

Label reconciliation failure during artwork change – CAPA ineffectiveness analysis

Analysis of Label Reconciliation Failures During Artwork Changes: A Real-World Case Study In pharmaceutical manufacturing, maintaining accurate labeling is paramount for compliance, safety, and data integrity. This article delves into…

Line clearance failure causing mix-up during artwork change – recall risk case study

Case Study of Line Clearance Issues Leading to Artwork Change Mix-Up In a recent incident within a pharmaceutical manufacturing facility, a line clearance failure during an artwork change resulted in…

Serialization mismatch detected during inspection – recall risk case study

Case Study on Serialization Mismatch Detected During Routine Inspection In a recent pharmaceutical manufacturing facility, a serialization mismatch was detected during a routine inspection, raising concerns over product traceability and…

Serialization mismatch detected during deviation review – CAPA ineffectiveness analysis

Addressing Serialization Mismatches During Deviation Review: A Comprehensive CAPA Analysis Serialization is a critical component in the pharmaceutical industry’s commitment to ensuring data integrity and product traceability. This article will…

FEFO not followed during inspection – inspection citation analysis

Case Study: Addressing FEFO Non-Compliance in Pharmaceutical Inspections In the ever-evolving landscape of pharmaceutical manufacturing, adherence to Good Manufacturing Practices (GMP) is critical for ensuring product quality and patient safety.…

FEFO not followed during material storage – product quality impact case study

Case Study: Impact of Ignoring FEFO Principles on Material Storage and Product Quality In pharmaceutical manufacturing, adherence to storage principles is crucial for ensuring product quality and regulatory compliance. One…

Expired material issued to production during material storage – inspection citation analysis

Analysis of an Incident Involving Expired Material in Pharmaceutical Production In a recent pharmaceutical manufacturing facility, a serious compliance issue arose when it was discovered that expired material had been…

Temperature excursion not assessed during distribution – inspection citation analysis

Analyzing a Temperature Excursion in Pharma Distribution: A Case Study Temperature excursions during pharmaceutical distribution can lead to serious compliance issues and impact product integrity. This case study examines a…

Excursion trend ignored during warehouse audit – product quality impact case study

Case Study: Ignoring Excursion Trends During Warehouse Audits and Its Quality Impact In the pharmaceutical industry, maintaining stringent quality control throughout every stage of product development and distribution is critical.…